Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death.
about
Role of autophagy in megakaryocyte differentiation and platelet formationPiecing together the humoral and cellular mechanisms of immune thrombocytopeniaCD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura.Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.Reduced antioxidant capacities in platelets from patients with autoimmune thrombocytopenia purpura (ITP).Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.Supportive care for thrombocytopenia in patients receiving treatment for myelodysplasia: a challenge for the future.Thrombopoiesis-stimulating agents and myelodysplastic syndromes.Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesThrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.Regulation of platelet lifespan by apoptosis.Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis.Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.Non-apoptotic functions of caspases in myeloid cell differentiation.
P2860
Q26749232-BF58F66D-D2BE-46A2-B31F-28CA55AD85A2Q27024841-1A32433E-F6C7-4803-A2B3-5081396A350DQ33377273-CE2D51B9-6590-41FA-AD6B-5138DDE38972Q33391229-CE66F286-05AC-40FE-B42B-1292D3AACBD5Q33397183-509DD4FA-7A06-49A8-867E-D2FBD2FCC3D2Q33399314-48832644-899D-4D06-9CE0-B44CF956D3F7Q33403765-1C4DF7A4-9ACE-4468-A98E-EEB4EBD95A3BQ33420207-67F06D96-DB44-4F59-B1F3-C36DC16AD472Q33424130-F3AA87A6-403D-4E54-902C-0444D71D0E38Q33424728-53CF42B9-2281-4499-BA5A-8AB95744D342Q33427023-00D2AD10-F23F-4AC5-AB28-C6F9FC823C97Q33431667-BE2813F6-5E81-4D11-BBD7-60170F6B7500Q33432575-C0B27F59-9443-46AB-A267-8F8EE551E67CQ33436918-DD49AC71-0C15-4414-B6DE-9D1ACA392BB0Q33439412-EBE7ADDC-021D-4E5A-BF8E-FE8EE1107CCFQ36358673-F0C318E3-C84D-4220-BB1B-779254813125Q39140591-FF0EF42B-2D12-44EF-930E-32D630FC987E
P2860
Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Megakaryocytic dysfunction in ...... different forms of cell death.
@ast
Megakaryocytic dysfunction in ...... different forms of cell death.
@en
type
label
Megakaryocytic dysfunction in ...... different forms of cell death.
@ast
Megakaryocytic dysfunction in ...... different forms of cell death.
@en
prefLabel
Megakaryocytic dysfunction in ...... different forms of cell death.
@ast
Megakaryocytic dysfunction in ...... different forms of cell death.
@en
P2093
P2860
P356
P1433
P1476
Megakaryocytic dysfunction in ...... different forms of cell death.
@en
P2093
Houwerzijl EJ
Vellenga E
de Wolf JT
van der Want JJ
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404385
P577
2006-09-07T00:00:00Z
P5875
P6179
1039319277